BMY

Bristol-Myers Squibb Company

Healthcare
60.74 +0.23 +0.38% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 124.04B
EV 162.88B
Shares Out 2.04B
Revenue (ttm) 48.48B
Net Income 7.28B
Beta —
P/E —
Forward P/E —
EPS (ttm) $3.57
P/S 2.55
P/B 6.17
P/FCF 10.40
P/C 9.30
EV/Sales 3.36
EV/EBITDA 45.33
ROA 8.03%
ROE 38.8%
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin 15.01%
Debt/Eq 2.41
LT Debt/Cap 67.75%
Quick Ratio 0.91
Current Ratio 1.42
Book/sh 9.85
Cash/sh 4.7
Div Yield 4.12%
Div TTM $2.50
Payout Ratio 70.03%
SMA20 5.92%
SMA50 6.63%
SMA200 11.06%
Volume 12,261,477
Avg Volume 11.88M
Rel Volume 1.03
Perf Week 2.36%
Perf Month 12.48%
Perf Quarter 2.72%
Perf Half Y 12.03%
Perf YTD 12.61%
Perf Year 28.25%
Perf 3Y -4.75%
Perf 5Y -8.96%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.6300
TTM Yield 4.12%
TTM Amount $2.50
Payout Ratio 70.03%
3-Yr Growth (CAGR) 4.37%
5-Yr Growth (CAGR) 6.24%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.6300
Q4 2025 ~2025-12-30 $0.6300
Q3 2025 ~2025-09-30 $0.6200
Q2 2025 ~2025-06-30 $0.6200
Q1 2025 ~2025-03-31 $0.6200
Q4 2024 ~2024-12-30 $0.6200
Q3 2024 ~2024-09-30 $0.6000
Q2 2024 ~2024-06-30 $0.6000
Q1 2024 ~2024-03-31 $0.6000
Q4 2023 ~2023-12-30 $0.6000
Q3 2023 ~2023-09-30 $0.5700
Q2 2023 ~2023-06-30 $0.5700

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Bristol-Myers Squibb Company is a global biopharmaceutical company dedicated to transforming patients' lives through science. The company discovers, develops and delivers…

Name
Bristol-Myers Squibb Company
Industry
Drug Manufacturers - General
CEO
Christopher S. Boerner · Board Chair and Chief Executive Officer
Employees
—
IPO Date
2019-03-12
Phone
(609) 252-4621
Address
Route 206 & Province Line Road, Princeton, NJ 08543
Website
—

Key Executives

Name Title FY Pay
Julia A. Haller Director —
Deepak L. Bhatt Director —
Peter J. Arduini Director —
Theodore R. Samuels Lead Independent Director —
Christopher S. Boerner Board Chair and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.